Loading
Aurobindo Pharma Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by K NAGARAJU, was filed 10 Mar 2023.
Insider Decl.
164
Thresholds
n/a
Buy Volume
€83,168
3 ops. · all time
Sell Volume
€10M
63 ops. · all time
Since the insiders bought
- +137.3%Entry ₹448.65 · Close at T+365 ₹1,064.70
- -26.7%Entry ₹639.55 · Close at T+365 ₹469.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Aurobindo Pharma Limited Buy (bullish), based on 27 analysts. Average price target: ₹1,747.70.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 9,194 of 26,284 companies
59.0
score / 100
Value49
Quality69
FCF yld2.6%
Earn yld3.8%
EV/EBITDA14.0x
ROE9.9%
Gross mgn57%
Net mgn10%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹1,621.40
Analyst consensus
27 analystsBuy
₹1,270.00Target ₹1,747.70(+8%)₹2,000.00
Income statement
Revenue₹333.8B
Gross profit₹190.6B57% margin
EBITDA₹72.2B22% margin
Net income₹35B10.6% margin
Valuation
PER (trailing)25.3x
PER (forward)17.4x
P/Book2.5x
Beta0.03
Balance sheet & cash
Market cap₹932.9B
Total debt₹80.7B
Free Cash Flow₹24.2B
Debt / Equity21%
Profitability & ownership
ROE9.9%
ROA5.9%
% insiders54.8%
% institutions29.3%
Last declaration on 30 March 2024
Declarations164 total
11,635,862 shares@ ₹1,088.7511.4% of flowEquity SharesSEBI:5e6c283adca6bfea5b27836809cf3ca381b6e7ce
16,700,000 shares@ ₹1,053.0515.7% of flowEquity SharesSEBI:67aa7b1e0f97fd1e83b4e56721569ec3a273a71f
1,000 shares@ ₹1,022.0044.2% of flowEquity SharesSEBI:c76bab9f89aadb29f9c0debc58ebc930712be0c7
2,000 shares@ ₹1,047.3875100.0% of flowEquity SharesSEBI:0a27db88c87689bbf58ab51b2460a877ac39a175
10,050,000 shares@ ₹1,043.809.5% of flowEquity SharesSEBI:ae693db06237826e067fc058b2c1697f6875ea91
2,300,000 shares@ ₹1,043.802.2% of flowEquity SharesSEBI:77b5a7d9adc270e847fb494111cc85be9a56511c
35,000 shares@ ₹1,017.11100.0% of flowEquity SharesSEBI:84d4ae9eb9a49dffb4b1dedecc6b363b7ad12f93
3,880 shares@ ₹1,011.0928100.0% of flowEquity SharesSEBI:cdc43a8ac1111e691637677a421b0cc98cee8957
1,300 shares@ ₹983.0032.6% of flowEquity SharesSEBI:71fa3f75e26e1ed579d9415152bf442871cbb87f
13,400,000 shares@ ₹996.1012.1% of flowEquity SharesSEBI:6fdea43e87a1ce84c066cc2fd65d923d1bc14671
2,000 shares@ ₹1,027.00100.0% of flowEquity SharesSEBI:f32b92c21022933d84e32558b34c814148790139
400,000 shares@ ₹1,124.800.4% of flowEquity SharesSEBI:8885e7d92541ff50c64b99164f9c9f5914a3cdb6
250,000 shares@ ₹1,118.850.2% of flowEquity SharesSEBI:d39909e7143ecf0c9f2cbcba68b8f240c2bbd3ac
1,000 shares@ ₹1,082.60100.0% of flowEquity SharesSEBI:ac0a8f8a76db047676dd5b8ca1f2b0b5644c24fb
1,000 shares@ ₹1,079.00100.0% of flowEquity SharesSEBI:c951329bc328c199a1218856efd3887f796545de
15,000 shares@ ₹1,071.6160.7% of flowEquity SharesSEBI:f86158fa16c626484a9ef5361db80291ce6e7ad4
9,000 shares@ ₹1,080.0162100.0% of flowEquity SharesSEBI:f0ce706da77de3c47b157ce7a04e0f091a23ac9c
4,000 shares@ ₹1,077.50100.0% of flowEquity SharesSEBI:16f1920e021956596fbbd3046d12ba17b63250bc
2,500 shares@ ₹1,085.0032.0% of flowEquity SharesSEBI:12ffb27351ca6b8706ea3f7014d84a0a6b2d31ca
1,500 shares@ ₹1,065.6667100.0% of flowEquity SharesSEBI:97a2e86bb3aacfde85f1f0c7ad30a6c5eebe1b74
3,500 shares@ ₹1,067.9863100.0% of flowEquity SharesSEBI:4c69fd9b6a247323cfddca168a15740fdb60247f
1,500 shares@ ₹1,044.00100.0% of flowEquity SharesSEBI:e8b13707769a951413941583412f3610ac113a92
1,000 shares@ ₹1,014.00100.0% of flowEquity SharesSEBI:6d45dc43a88b76419c27dea6e1055aed8032cfa4
3,000 shares@ ₹1,040.5011.7% of flowEquity SharesSEBI:85fd80c8469e974740bf05287bc279b5a48366cf
1,350 shares@ ₹1,022.40100.0% of flowEquity SharesSEBI:341d575722aca4b11c47ea3f5cca633fa64cc343
25 of 164 declarations
About Aurobindo Pharma Limited
At Aurobindo Pharma Limited, the file is dominated by sales: 63, worth EUR 9,525,564 with a median of EUR 23,332, against 3 purchases worth EUR 83,168. The largest, EUR 6,752,143, is by Kambam Spoorthi on June 14, 2021, far ahead of K Bharathi (EUR 397,888 on February 13, 2024) and S Sadananda Reddy (EUR 176,044 on December 20, 2023). The purchases are by Venugopalan Muralidharan, EUR 41,209 on November 15, 2021, K Nagaraju, EUR 37,207 on March 6, 2023, and Jayakumar Reddy Guduru, EUR 4,752 on April 1, 2021.
This Indian Healthcare company, listed on the Bombay Stock Exchange and valued at INR 932.9 billion, has 60 filers, who hold 54.8% of the capital. A joint-holding label (RPR SONS ADVISORS PVT.LTD., P.SUNEELA RANI) totals 60 filings, none classed as a purchase or a sale.
Read moreShow less
Of 164 filings published from March 3, 2021 to March 30, 2024, 82 date from 2021, 48 from 2023, 20 from 2022 and 14 from 2024. None is recent. The median publication delay is 2 days.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
